| INTRODUCTION
Immune-mediated myositis (IMM) in American Quarter Horses (QHs) causes recurrent episodes of acute epaxial and gluteal muscle atrophy. 1 Susceptibility to IMM was recently attributed to an E321G missense mutation in the myosin heavy chain 1 (MYH1) gene encoding type IIX myosin heavy chain that alters the amino acid composition of the globular head region, potentially impacting protein stability. 2 In horses carrying this allele, exposure of the novel myosin isoform to the extracellular environment appears to initiate lymphocytic infiltration and destruction of predominantly type IIX myofibers. 2 More recently, this same genetic variant was associated with nonexertional rhabdomyolysis (non-ER) in QHs with or without atrophy and lymphocytic infiltrates. The objective of our study was to estimate the E321G MYH1 variant frequency in the general QH population and in 7 distinct subpopulations of QHs used for barrel racing, cutting, halter, racing, reining, Western Pleasure, and working cow horse competitions.
| MATERIALS AND METHODS

| Study design
This was a prospective, genetic study of AQHA-registered horses in which the authors were blinded to the identity of individual horses.
| Samples
With permission from the AQHA, the association's animal registration records were examined to select the study population described herein. Each horse was assigned a random study ID number by personnel uninvolved in the genotyping for this project to maintain animal anonymity. Mane hair samples from each horse were provided by the Veterinary Genetics Laboratory (VGL), University of California, Davis, which houses the AQHA's repository of hair samples from all registered animals.
| Selection criteria for whole-population controls
A random sampling scheme was used to select control QHs for estimating the whole-breed frequency of the E321G MYH1 variant.
Between March 2013 and September 2017, a single week day per month was randomly selected, and on that date, every 10th QH hair sample submitted by the AQHA to the VGL for DNA testing was selected until 40 samples with sufficient hair follicles for subsampling were available for each year in the sampling period. In total, 200 controls were sampled, and anonymized hair samples were provided.
| Selection criteria for performance horses
The eligibility criteria for elite horses in the 7 performance subgroups of interest (barrel racing, cutting, halter, racing, reining, Western Pleasure, and working cow) were placement in the list of 75 AQHAregistered horses that had earned the most competition points (halter discipline) or sport money (all other disciplines) in the United States between January 1, 2014, and June 15, 2017. Records of sport money and competition point earnings were obtained from an online records company 12 for all disciplines except racing, for which records were obtained directly from the AQHA. 13 
| Genotyping
Genomic DNA was isolated from each horse's hair sample using the Gentra Puregene Tissue Kit (QIAGEN, Germantown, Maryland).
Genotyping was performed by pyrosequencing. Forward, reverse, and sequencing primers were designed using Pyrosequencing Assay containing the site (ECA11: 52993878) of the E321G MYH1 variant.
The resulting amplicon was annealed with the sequencing primer (5 0 -TGCTGGGGACTGTGA-3 0 ), and the relative expression of each allele was determined by pyrosequencing following manufacturer protocol using the PyroMark Gold Q96 Kit (QIAGEN). All sample plates were analyzed using a positive control and no template control, with the resulting data collated and genotypes inferred and tabulated for further analysis.
In addition, pyrosequencing results were validated in a subset of horses using a polymerase chain reaction (PCR) assay and Sanger sequencing protocol previously described for evaluating the E321G
MYH1 variant in QHs. 2 Control and performance horses from our study were pooled after genotyping by pyrosequencing, and 5 horses from each MYH1 genotype group (ie, homozygous wild type, heterozygous, and homozygous alternative) were selected by computer randomization to have their samples used for this validation step.
| Allele frequency and standard error calculations
Spreadsheet software 14 was used to calculate a basic allele frequency for the general QH population and each of the 7 performance subgroups according to the formula
where My represents the E321G MYH1 variant, N represents the wild-type MYH1 allele, H X represents the number of horses with genotype X, and n is the total number of horses in the study population for which allele frequency is being calculated. Because multinomial sampling schemes were used to select the study populations, standard error (SE) associated with each allele frequency calculation was also estimated according to the formula
Chi-square contingency tests were performed using the same software to determine if the frequency of the E321G MYH1 variant in each of the performance subgroups was statistically significantly different when compared to the control group. 
| Allele frequency in performance subgroups
The elite performance QHs utilized in our study had YOB ranging The American QH is a prolific breed, with over 2.8 million AQHAregistered animals alive worldwide in 2017, and is the most popular type of horse used in over 14 recognized equestrian sports in the United States. 16 Individual QHs must possess specific and often disparate characteristics to excel in their respective disciplines (eg, a compact and heavily muscled body type is ideal for horses used to work livestock, whereas longer-legged and leaner animals are preferred for racing and hunter classes). Thus, although American QHs retain a remarkable level of genetic diversity when considered as a single population, the differential selective pressures required to succeed in various disciplines has led to marked population stratification within the breed.
This has been demonstrated in recent analyses of genetic relatedness among performance subgroups of QHs, including 6 groups (not including barrel racing) examined in the present study of E321G MYH1 variant frequency. 17 Our investigation supports previous suggestions that it is incorrect to assume without a confirmatory genetic survey that the frequency of a disease allele in 1 performance subgroup of QHs is similar to that in a different subgroup or the whole breed. 4 On average, the prevalence of the E321G MYH1 variant was 54% different in magnitude among the 5 performance subgroups in this survey.
Within the performance subtypes examined in our study, the 
